Novavax, Inc. Share Price Today: Live Updates & Key Insights

Novavax, Inc. share price today is $9.61, up -1.23%. The stock opened at $9.83 against the previous close of $9.74, with an intraday high of $10 and low of $9.42.

Novavax, Inc. Share Price Chart

Novavax, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Novavax, Inc. Share Price Performance

$9.61 -0.0123(-1.23%) NVAX at 23 Mar 2026 02:31 PM Biotechnology
Lowest Today 9.42
Highest Today 10
Today’s Open 9.83
Prev. Close 9.74
52 Week High 11.97
52 Week Low 5.01
Day’s Range: Low 9.42 High 10
52-Week Range: Low 5.01 High 11.97
1 day return -
1 Week return -4.65
1 month return +2.77
3 month return +39.82
6 month return +8.51
1 year return +25.26
3 year return +66.43
5 year return -95.95
10 year return -

Novavax, Inc. Institutional Holdings

Vanguard Group Inc 9.49

Shah Capital Management 8.94

BlackRock Inc 7.84

State Street Corp 4.42

Sanofi 4.22

D. E. Shaw & Co LP 3.68

State Street® SPDR® S&P® Biotech ETF 3.39

Vanguard Total Stock Mkt Idx Inv 3.13

Millennium Management LLC 2.74

Geode Capital Management, LLC 2.28

Vanguard Small Cap Index 2.26

iShares Russell 2000 ETF 2.23

UBS Group AG 2.16

Bank of America Corp 1.90

PIMCO RAE US Small 1.08

PIMCO RAE US Small Instl 1.08

Vanguard Institutional Extnd Mkt Idx Tr 1.07

Northern Trust Corp 0.94

Fidelity Small Cap Index 0.90

Allianz Asset Management AG 0.87

TSP Capital Management Group/LLC 0.85

Charles Schwab Investment Management Inc 0.82

Vanguard Small Cap Value Index Inv 0.73

Royal Bank of Canada 0.70

iShares Biotechnology ETF 0.68

Morgan Stanley - Brokerage Accounts 0.66

Citadel Advisors Llc 0.66

iShares Russell 2000 Growth ETF 0.63

Vanguard Small Cap Growth Index Inv 0.63

Marshall Wace Asset Management Ltd 0.57

SG Americas Securities, LLC 0.56

State St Russell Sm/Mid Cp® Indx SL Cl I 0.55

Fidelity Extended Market Index 0.51

HRT FINANCIAL LLC 0.51

Schwab US Small-Cap ETF™ 0.48

Vanguard Russell 2000 ETF 0.44

PIMCO RAE US Small CIT CL 0TS 0.32

State St Russell Sm Cap® Indx SL Cl I 0.30

Stt Strt®SPDR®S&PKenshoNwEcosComposETF 0.29

Vanguard Health Care ETF 0.26

Novavax, Inc. Market Status

Strong Buy: 3

Buy: 1

Hold: 2

Sell: 1

Strong Sell: 0

Novavax, Inc. Fundamentals

Market Cap 1567.44 M

PB Ratio 33.1966

PE Ratio 3.7725

Enterprise Value 1100.72 M

Total Assets 1176.51 M

Volume 5683771

Novavax, Inc. Company Financials

Annual Revenue FY25:1123479000 1123.5M, FY23:973730000 973.7M, FY22:1598951000 1599.0M, FY21:1146290000 1146.3M, FY20:475598000 475.6M

Annual Profit FY25:1050439000 1050.4M, FY23:603173000 603.2M, FY22:696312000 696.3M, FY21:1146290000 1146.3M, FY20:475598000 475.6M

Annual Net worth FY25:440302000 440.3M, FY23:-548922000 -548.9M, FY22:-657939000 -657.9M, FY21:-1743751000 -1743.8M, FY20:-427505000 -427.5M

Quarterly Revenue Q4/2025:147139000 147.1M, Q3/2025:70445000 70.4M, Q2/2025:239240000 239.2M, Q1/2025:666655000 666.7M, Q3/2024:84512000 84.5M

Quarterly Profit Q4/2025:123935000 123.9M, Q3/2025:48949000 48.9M, Q2/2025:225015000 225.0M, Q1/2025:652540000 652.5M, Q3/2024:23893000 23.9M

Quarterly Net worth Q4/2025:17527000 17.5M, Q3/2025:-202379000 -202.4M, Q2/2025:106508000 106.5M, Q1/2025:518646000 518.6M, Q3/2024:-121300000 -121.3M

About Novavax, Inc. & investment objective

Company Information Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Organisation Biotechnology

Employees 749

Industry Biotechnology

CEO Mr. John Charles Jacobs M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Novavax, Inc. FAQs

What is the share price of Novavax, Inc. today?

The current share price of Novavax, Inc. is $9.61.

Can I buy Novavax, Inc. shares in India?

Yes, Indian investors can buy Novavax, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Novavax, Inc. shares in India?

You can easily invest in Novavax, Inc. shares from India by:

Can I buy fractional shares of Novavax, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Novavax, Inc.?

Novavax, Inc. has a market cap of $1567.44 M.

In which sector does Novavax, Inc. belong?

Novavax, Inc. operates in the Biotechnology sector.

What documents are required to invest in Novavax, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Novavax, Inc.?

The PE ratio of Novavax, Inc. is 3.77 and the PB ratio is 33.20.